What is Artiva Biotherapeutics, Inc.'s enterprise value?

Artiva Biotherapeutics, Inc. (ARTV) reported enterprise value of $148.02M in Q1 2026.

How has Artiva Biotherapeutics, Inc.'s enterprise value changed year-over-year?

Artiva Biotherapeutics, Inc.'s enterprise value increased by 163.3% year-over-year, from $56.22M to $148.02M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

Artiva Biotherapeutics, Inc. ARTV Enterprise value

Enterprise value at other companies

Bristol-Myers SquibbBMY

$158.92B-2.6%

Gilead SciencesGILD

$187.53B+19.7%

Kyverna Therapeutics, Inc.KYTX

$498.7M+1,393%

Allogene TherapeuticsALLO

$635.27M+79.8%

Immix Biopharma, Inc.IMMX

$404.29M+1,175%

ImmunityBio, Inc.IBRX

$8.16B+187%

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Calculated from Artiva Biotherapeutics, Inc.’s reported figures.

$159.2Mmarket cap+$10.3Mtotal debt−$21.4Mcash and equivalents=$148.02M

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s enterprise value?: Artiva Biotherapeutics, Inc. (ARTV) reported enterprise value of $148.02M in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s enterprise value changed year-over-year?: Artiva Biotherapeutics, Inc.'s enterprise value increased by 163.3% year-over-year, from $56.22M to $148.02M.
What does enterprise value mean?: Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.